DXR.US Daxor Corporation

Healthcare Health Care Equipment & Supplies USA Stocks
8.48 USD
Close of Nov 14, 2026
8.24 14.76
Market cap
USD 49.5M
P/E
7.7x
P/B
0.95x
ROE
-25.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is DXR.US undervalued?

Graham number
Price8.48
Graham value14.84
Discount42.9%

DXR.US trades 42.9% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Daxor Corporation fundamental analysis

No fundamental analysis for Daxor Corporation yet.

Daxor Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Daxor Corporation

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Da…

Full company profile